Congo vs Pakistan: Tuberculosis patients living with HIV receiving antiretroviral therapy
Congo
621 patients
in 2021
Pakistan
637 patients
in 2021
Congo rank
45th
Pakistan rank
43rd
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Congo
- Pakistan
How they compare
Pakistan currently reports 637 patients against 621 patients in Congo, a difference of 16 patients.
The two have swapped places 6 times across 16 shared years of data; in 2006 it was Pakistan ahead.
Congo ranks 45th and Pakistan ranks 43rd of 183 countries.
Congo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 56.5 patients | 7.25 patients | 49.25 patients | Congo |
| 2010s | 190.2 patients | 131.5 patients | 58.7 patients | Congo |
| 2020s | 556 patients | 500.5 patients | 55.5 patients | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Congo or Pakistan?
- Pakistan, at 637 patients against 621 patients in Congo as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Congo and Pakistan?
- 16 patients, with Pakistan ahead.
- How many years of comparable data are there for Congo and Pakistan?
- 16 years are reported by both, from 2006 to 2021.
- How do Congo and Pakistan rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Congo ranks 45th and Pakistan ranks 43rd of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.